Participant flow14

How many started, completed or left each group, period by period.

1 to 14 of 14

Period	Milestone	Group	Participants
Overall Study	STARTED	Givinostat	34
Overall Study	STARTED	Placebo	17
Overall Study	Per Protocol	Givinostat	25
Overall Study	Per Protocol	Placebo	14
Overall Study	ITT	Givinostat	34
Overall Study	ITT	Placebo	17
Overall Study	Safety	Givinostat	34
Overall Study	Safety	Placebo	17
Overall Study	PK	Givinostat	34
Overall Study	PK	Placebo	17
Overall Study	COMPLETED	Givinostat	30
Overall Study	COMPLETED	Placebo	17
Overall Study	NOT COMPLETED	Givinostat	4
Overall Study	NOT COMPLETED	Placebo	0

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03238235/flow